Search Within

Martin Henner Voss

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (54)
  2. Meeting Abstract (45)
  3. Review (2)
  4. Correspondence (1)
  5. Editorial (1)
  6. Research Letter (1)
Groups
  1. Department of Medicine (104)
  2. Genitourinary Oncology Service (104)
  3. Human Oncology and Pathogenesis Program (104)
  4. Solid Tumor Oncology Division (104)
  5. Surgery (97)
  6. Urology (96)

More Groups

People
  1. Abraham Hakimi (95)
  2. Robert Motzer (91)
  3. Paul Russo (51)
  4. Jonathan Coleman (40)
  5. Yingbei Chen (40)
  6. James Hsieh (39)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (6)
  4. 2022 (8)
  5. 2021 (11)
  6. 2020 (13)

More Years

Publications
  1. Journal of Clinical Oncology (35)
  2. Clinical Cancer Research (7)
  3. BJU International (5)
  4. European Urology Focus (5)
  5. European Urology (4)
  6. Cancer (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (38)
  2. American Association for Cancer Research (13)
  3. Elsevier Science, Inc. (9)
  4. Wiley Blackwell (8)
  5. Elsevier Inc. (7)
  6. Elsevier B.V. (6)

More Publishers

Results (104)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma
    Journal Article

    Hakimi, A. A.; Chen, Y. B.; Wren, J.; Gonen, M.; Abdel-Wahab, O.; Heguy, A.; Liu, H.; Takeda, S.; Tickoo, S. K.; Reuter, V. E.; more...
    European Urology (2013)

    Fulltext@MSK | Save
  • Genetic determinants of long-term response to rapalog therapy in advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Voss, M. H.; Hakimi, A. A.; Scott, S. N.; Takeda, S.; Liu, H.; Chen, Y.; Motzer, R. J.; Berger, M. F.; Hsieh, J.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Next-generation sequencing reveals genomic determinants of long-term response to mTOR inhibitors in patients with advanced RCC
    Meeting Abstract

    Voss, M. H.; Hakimi, A. A.; Brannon, A. R.; Scott, S.; Takeda, S.; Liu, H.; Chen, Y.; Motzer, R. J.; Berger, M. F.; Hsieh, J. J.
    BJU International (2012)

    Fulltext@MSK | Save
  • Tumor suppressor screens of 3p chromatin modulators link BAP1 mutations to poor clinical outcomes in clear cell renal cell carcinoma
    Meeting Abstract

    Hakimi, A. A.; Chen, Y. B.; Wren, J.; Ostrovnaya, I.; Gonen, M.; Abdel-Wahab, O.; Heguy, A.; Liu, H.; Takeda, S.; Tickoo, S. K.; more...
    BJU International (2012)

    Fulltext@MSK | Save